Xiaoyan Ke
Overview
Explore the profile of Xiaoyan Ke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
2072
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
He F, Luo J, Huang Y, Hao Y, Sun L, Ke X, et al.
Child Adolesc Psychiatry Ment Health
. 2024 Jul;
18(1):88.
PMID: 39026306
Background: Aripiprazole is the most frequently recommended antipsychotic for the treatment of tics in children and adolescents with Tourette's disorder (TD). However, to date, a randomized controlled trial for aripiprazole...
12.
Xue F, Zheng P, Yang F, Liu R, Feng S, Guo Y, et al.
Front Oncol
. 2024 Jul;
14:1376490.
PMID: 38983927
Background And Aims: Patients with relapsed/refractory aggressive B-cell lymphoma(r/r aBCL)who progressed after CD19-specific chimeric antigen receptor T-cell therapy (CD19CART) had a poor prognosis. Application of CAR T-cells targeting a second...
13.
Zhang Z, Zhu Q, Gao T, Gan K, Wang F, Guan L, et al.
J Autism Dev Disord
. 2024 May;
PMID: 38700779
The First Year Inventory (FYI) is a parent report screening measure, aimed at identifying the risk of autism spectrum disorder (ASD) in 12-month-old infants. This study aimed to investigate the...
14.
Jiang X, Shou X, Zhao Z, Chen Y, Meng F, Le J, et al.
Psychoradiology
. 2024 Apr;
3:kkad005.
PMID: 38666122
Background: Autism spectrum disorder (ASD) is associated with altered brain development, but it is unclear which specific structural changes may serve as potential diagnostic markers, particularly in young children at...
15.
Shi H, Yang F, Cao M, Xu T, Zheng P, Guo Y, et al.
Ann Hematol
. 2024 Apr;
103(8):2993-3004.
PMID: 38662205
The prognosis of patients diagnosed with relapsed or refractory (R/R) T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) has consistently been unsatisfactory, with limited treatment options. As reports, the CAG regimen can serve as a...
16.
Luo L, Jiao Y, Li Y, Yang P, Gao J, Huang S, et al.
Ann Hematol
. 2024 Apr;
103(6):2073-2087.
PMID: 38581546
T lymphoblastic leukemia /lymphoma (T-ALL/LBL) is a rare and highly aggressive neoplasm of lymphoblasts. We evaluated 195 T-ALL/LBL adolescent and adult patients who received ALL-type chemotherapy alone (chemo,n = 72)...
17.
Song Y, Li J, Zhou K, Ke X, Cai Z, Zhang H, et al.
Leuk Lymphoma
. 2024 Apr;
65(5):647-652.
PMID: 38557285
Acalabrutinib studies have limited Asian participation. This phase 1/2 study (NCT03932331) assessed acalabrutinib in Chinese patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL). Primary endpoint was blinded independent central review...
18.
Wei Q, Xiao Y, Yang T, Chen J, Chen L, Wang K, et al.
Psychiatry Res
. 2024 Mar;
334:115789.
PMID: 38452495
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a complex environmental etiology involving maternal risk factors, which have been combined with machine learning to predict ASD. However, limited studies...
19.
Ding N, Fu L, Qian L, Sun B, Li C, Gao H, et al.
Eur Child Adolesc Psychiatry
. 2024 Feb;
33(9):3247-3262.
PMID: 38402375
As indicated by longitudinal observation, autism has difficulty controlling emotions to a certain extent in early childhood, and most children's emotional and behavioral problems are further aggravated with the growth...
20.
Xia Z, Leng Y, Fang B, Liang Y, Li W, Fu C, et al.
BMC Cancer
. 2023 Oct;
23(1):980.
PMID: 37838670
Background: Aponermin, a circularly permuted tumor necrosis factor-related apoptosis-inducing ligand, is a potential death receptor 4/5-targeted antitumour candidate. Previous phase 1/2 studies have demonstrated the efficacy of aponermin in patients...